Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017, Article ID 9548478, 7 pages
https://doi.org/10.1155/2017/9548478
Research Article

Integrating a 19F MRI Tracer Agent into the Clinical Scale Manufacturing of a T-Cell Immunotherapy

1Celsense Inc., 603 Stanwix Street Suite 390, Pittsburgh, PA 15222, USA
2GE Healthcare, 100 Results Way, Marlborough, MA 01752, USA
3GE Healthcare, The Grove Center, White Lion Road, Amersham, Buckinghamshire HP7 9LL, UK

Correspondence should be addressed to Brooke M. Helfer; moc.esneslec@ekoorb

Received 10 July 2017; Revised 19 September 2017; Accepted 2 October 2017; Published 2 November 2017

Academic Editor: Anne Roivainen

Copyright © 2017 Charles F. O’Hanlon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Charles F. O’Hanlon, Tamara Fedczyna, Shannon Eaker, William D. Shingleton, and Brooke M. Helfer, “Integrating a 19F MRI Tracer Agent into the Clinical Scale Manufacturing of a T-Cell Immunotherapy,” Contrast Media & Molecular Imaging, vol. 2017, Article ID 9548478, 7 pages, 2017. https://doi.org/10.1155/2017/9548478.